SEC INSIDER TRANSACTIONS

Xylem Inc. (XYL) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

XYL · Xylem Inc.

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-11-13 · 20 filings · fetched 2026-11-13T20:57:54Z

Recent reported activity

1purchase rows on this page

0sale rows on this page

17matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-10-29Filed 2026-10-29	KOCH D CHRISTIANDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 11,000 Shares were purchased at a range of prices from $89.52 to $89.67. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares purchased at each price. References: F1	P Purchase (market/private)Common Stock · Non-derivative	11,000A	89.6	Direct	Form 4 ↗0001524472-26-000150
2026-10-21Filed 2026-10-21	Emmerich MeredithOfficer · EVP & President, MCS Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on October 21, 2024 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). References: F1	F WithholdingCommon Stock · Non-derivative	837D	106.35	Direct	Form 4 ↗0001524472-26-000140
2026-10-01Filed 2026-10-09Amendment	McShane Geri-MichelleOfficer · SVP, CAO Filing context Amendment: compare with original; not an additional trade. F1 This Form 4/A is being filed solely to correct the number of restricted stock units granted on October 1, 2026. The original Form 4 inadvertently reported 4,225 restricted stock units. The correct number of restricted stock units granted was 4,257. Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-half increments on October 1, 2028, and October 1, 2029. References: F1	A Award / grantCommon Stock · Non-derivative	4,257A	0	Direct	Form 4/A ↗0001524472-26-000138
2026-10-01Filed 2026-10-01	McShane Geri-MichelleOfficer · SVP, CAO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-half increments on October 1, 2028, and October 1, 2029. References: F1	A Award / grantCommon Stock · Non-derivative	4,225A	0	Direct	Form 4 ↗0001524472-26-000136
2026-09-01Filed 2026-09-02	van der Berg Andrea MicheleOfficer · EVP & Chief Financial Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028, and March 1, 2029. F2 Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028, and March 1, 2029. References: F2	A Award / grantStock Options (Right to Buy) · Derivative	6,034A	106.89	Direct	Form 4 ↗0001524472-26-000129
2026-09-01Filed 2026-09-02	van der Berg Andrea MicheleOfficer · EVP & Chief Financial Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028, and March 1, 2029. F2 Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028, and March 1, 2029. References: F1	A Award / grantCommon Stock · Non-derivative	1,693A	0	Direct	Form 4 ↗0001524472-26-000129
2026-09-01Filed 2026-09-02	Johnston Joseph PatrickOfficer · EVP & President, AW Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028, and March 1, 2029. F2 Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028, and March 1, 2029. References: F2	A Award / grantStock Options (Right to Buy) · Derivative	2,298A	106.89	Direct	Form 4 ↗0001524472-26-000128
2026-09-01Filed 2026-09-02	Johnston Joseph PatrickOfficer · EVP & President, AW Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028, and March 1, 2029. F2 Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028, and March 1, 2029. References: F1	A Award / grantCommon Stock · Non-derivative	645A	0	Direct	Form 4 ↗0001524472-26-000128
2026-08-13Filed 2026-08-14	KOCH D CHRISTIANDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2027 Annual Meeting of Shareholders, unless the Reporting Person timely elects deferral in the Company's Deferred Compensation Plan. References: F1	A Award / grantCommon Stock · Non-derivative	1,247A	120.27	Direct	Form 4 ↗0001524472-26-000120
2026-05-14Filed 2026-05-15	Yadav UdayDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2027 Annual Meeting of Shareholders. References: F1	A Award / grantCommon Stock · Non-derivative	1,711A	116.88	Direct	Form 4 ↗0001524472-26-000088
2026-05-14Filed 2026-05-15	Tretikov LilaDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2027 Annual Meeting of Shareholders. F2 Includes additional shares due to dividend reinvestment. References: F1, F2	A Award / grantCommon Stock · Non-derivative	1,711A	116.88	Direct	Form 4 ↗0001524472-26-000087
2026-05-14Filed 2026-05-15	Peribere Jerome ADirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2027 Annual Meeting of Shareholders. The Reporting Person has elected to defer the settlement of the RSU Award until February 1, 2028. References: F1	A Award / grantCommon Stock · Non-derivative	1,711A	116.88	Direct	Form 4 ↗0001524472-26-000086
2026-05-14Filed 2026-05-15	Morelli Mark DDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2027 Annual Meeting of Shareholders. The Reporting Person has elected to defer the settlement of the RSU Award until Separation from Service. F2 Includes additional shares due to dividend reinvestment. References: F1, F2	A Award / grantCommon Stock · Non-derivative	1,711A	116.88	Direct	Form 4 ↗0001524472-26-000085
2026-05-14Filed 2026-05-15	Harker Victoria DDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2027 Annual Meeting of Shareholders. References: F1	A Award / grantCommon Stock · Non-derivative	1,711A	116.88	Direct	Form 4 ↗0001524472-26-000084
2026-05-14Filed 2026-05-15	Glatch LisaDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2027 Annual Meeting of Shareholders. References: F1	A Award / grantCommon Stock · Non-derivative	1,711A	116.88	Direct	Form 4 ↗0001524472-26-000083
2026-05-14Filed 2026-05-15	FRIEL ROBERT FDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2027 Annual Meeting of Shareholders. The Reporting Person has elected to defer the settlement of the RSU Award until Separation from Service. F2 Includes additional shares due to dividend reinvestment. References: F1, F2	A Award / grantCommon Stock · Non-derivative	2,481A	116.88	Direct	Form 4 ↗0001524472-26-000082
2026-05-14Filed 2026-05-15	ELLIS EARL RAYDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2027 Annual Meeting of Shareholders. The Reporting Person has elected to defer the settlement of the RSU award until Separation of Service. F2 Includes additional shares due to dividend reinvestment. References: F1, F2	A Award / grantCommon Stock · Non-derivative	1,711A	116.88	Direct	Form 4 ↗0001524472-26-000081

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.